Celularity Inc

Celularity Inc., filing under the ticker GXGX, submitted an amended registration statement on Form S-1/A with the Securities and Exchange Commission on February 13, 2025, as the company continues to work through the SEC review process ahead of its public offering. The S-1/A, assigned accession number 0001493152-25-006219, updates a previously submitted registration statement and signals active engagement between the issuer and regulators. Celularity operates in the healthcare and life sciences sector, with a focus on cell therapy and regenerative medicine, areas that have drawn consistent attention from blank-check vehicles and SPAC sponsors. SpacDesk tracks GXGX alongside hundreds of active SPAC-related filings in real time. Sign up at SpacDesk for complete filing history, sponsor profiles, and deal-level analytics on GXGX.